Literature DB >> 12183162

Variable receptors controlling activation and inhibition of NK cells.

Karina L McQueen1, Peter Parham.   

Abstract

NK cells are important effector lymphocytes of innate immunity; they kill infected cells and produce cytokines that stimulate other immune effects. Once considered relatively homogeneous, NK cells are now seen to be highly diverse. Within an individual, expression of different combinations of inhibitory and stimulatory receptors creates a diverse NK cell repertoire, which exhibits specificity in the immune response. Rapid evolution of NK cell receptor gene families distinguishes members of a species and causes substantial species-specific differences in NK cell receptor systems. All known ligands for these diverse receptors are MHC class I molecules, or molecules of host or pathogen origin that are homologous to MHC class I.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183162     DOI: 10.1016/s0952-7915(02)00380-1

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  45 in total

1.  Ly49 genes in non-rodent mammals.

Authors:  Liane Gagnier; Brian T Wilhelm; Dixie L Mager
Journal:  Immunogenetics       Date:  2003-04-24       Impact factor: 2.846

2.  Ly49Q, a member of the Ly49 family that is selectively expressed on myeloid lineage cells and involved in regulation of cytoskeletal architecture.

Authors:  Noriko Toyama-Sorimachi; Yusuke Tsujimura; Mikako Maruya; Atsuko Onoda; Toshiyuki Kubota; Shigeo Koyasu; Kayo Inaba; Hajime Karasuyama
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-19       Impact factor: 11.205

3.  Novel immunoglobulin-like transcripts in teleost fish encode polymorphic receptors with cytoplasmic ITAM or ITIM and a new structural Ig domain similar to the natural cytotoxicity receptor NKp44.

Authors:  René J M Stet; Trudi Hermsen; Adrie H Westphal; Jojanneke Jukes; Marc Engelsma; B M Lidy Verburg-van Kemenade; Jos Dortmans; Joao Aveiro; Huub F J Savelkoul
Journal:  Immunogenetics       Date:  2005-02-09       Impact factor: 2.846

Review 4.  Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors.

Authors:  Lu Deng; Roy A Mariuzza
Journal:  Semin Immunol       Date:  2006-06       Impact factor: 11.130

Review 5.  NK cells and immune "memory".

Authors:  Joseph C Sun; Sandra Lopez-Verges; Charles C Kim; Joseph L DeRisi; Lewis L Lanier
Journal:  J Immunol       Date:  2011-02-15       Impact factor: 5.422

6.  Immune-related, lectin-like receptors are differentially expressed in the myeloid and lymphoid lineages of zebrafish.

Authors:  Patoula G Panagos; Kimberly P Dobrinski; Xianghong Chen; Amanda W Grant; David Traver; Julie Y Djeu; Sheng Wei; Jeffrey A Yoder
Journal:  Immunogenetics       Date:  2006-02-09       Impact factor: 2.846

7.  A positive cooperativity binding model between Ly49 natural killer cell receptors and the viral immunoevasin m157: kinetic and thermodynamic studies.

Authors:  Pablo N Romasanta; Lucrecia M Curto; Nicolas Urtasun; María B Sarratea; Santiago Chiappini; María V Miranda; José M Delfino; Roy A Mariuzza; Marisa M Fernández; Emilio L Malchiodi
Journal:  J Biol Chem       Date:  2013-12-30       Impact factor: 5.157

8.  Molecular architecture of the major histocompatibility complex class I-binding site of Ly49 natural killer cell receptors.

Authors:  Lu Deng; Sangwoo Cho; Emilio L Malchiodi; Melissa C Kerzic; Julie Dam; Roy A Mariuzza
Journal:  J Biol Chem       Date:  2008-04-21       Impact factor: 5.157

9.  Presence of more activating KIR genes is associated with Hashimoto's thyroiditis.

Authors:  Elham Ashouri; Mohammad Hossein Dabbaghmanesh; Gholamhossein Ranjbar Omrani
Journal:  Endocrine       Date:  2013-10-31       Impact factor: 3.633

10.  Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells.

Authors:  Valentina Voigt; Catherine A Forbes; Joanne N Tonkin; Mariapia A Degli-Esposti; Hamish R C Smith; Wayne M Yokoyama; Anthony A Scalzo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.